TrialHealth and quality of life outcomes2023

Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant.

Carol Jamieson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.